Innovent Biologics (suzhou) Co. Ltd.

This study is testing whether the drug IBI311 can reduce eye bulging in people with inactive thyroid eye disease. About 111 participants will receive either the drug or a placebo over 24 weeks to see which is more effective. The main goal is to measure how much eye bulging decrea…

This study tests an experimental drug called IBI362 to help Chinese teenagers (ages 12-17) with obesity or overweight lose weight. Participants must have already tried diet and exercise for at least 12 weeks without losing 5 kg. The trial compares the drug to a placebo to see if …

This early-stage study is testing a single injection of a new antibody (Anti-IL-RAP) to see if it is safe and how it works in the body. It includes 64 people: healthy volunteers and those currently having an acute gout flare. The goal is to gather safety data and understand the d…